41 studies found for:    "Central serous chorioretinopathy"
Show Display Options
Rank Status Study
1 Completed
Has Results
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention:
2 Recruiting Eplerenone for the Treatment of Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: 25mg Eplerenone;   Drug: Placebo
3 Completed High-dose Antioxidants for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: antioxidants tablets
4 Recruiting Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone 50mg
5 Recruiting The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: Photodynamic therapy
6 Not yet recruiting A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Eplerenone;   Drug: Maltodextrin
7 Not yet recruiting Methotrexate for Central Serous Chorioretinopathy Treatment Trial
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Methotrexate;   Drug: Delayed treatment
8 Recruiting Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Conditions: Age Related Macular Degeneration;   Choroidal Neovascularization;   Central Serous Chorioretinopathy
Intervention:
9 Completed
Has Results
Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
Condition: Chronic Central Serous Chorioretinopathy
Interventions: Drug: Verteporfin;   Drug: ranibizumab
10 Recruiting Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy
Condition: Chronic Central Serous Chorioretinopathy
Interventions: Procedure: Half-dose photodynamic therapy (PDT);   Procedure: Micropulse laser (ML) treatment
11 Completed Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
Condition: Chronic Central Serous Chorioretinopathy
Interventions: Drug: Anecortave Acetate Sterile suspension 15 mg;   Drug: Anecortave Acetate
12 Recruiting Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Intravitreal Aflibercept injection;   Drug: Sham injection;   Procedure: Half-fluence photodynamic therapy
13 Completed Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Verteporfin PDT, half-dose;   Drug: verteporfin PDT, half-fluence
14 Recruiting Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Device: Micropulse Laser Treatment
15 Completed Central Serous Chorioretinopathy: Etiology, Course and Prognosis
Condition: Central Serous Chorioretinopathy
Intervention:
16 Completed Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: Subthreshold diode micropulse laser
17 Active, not recruiting The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Intravitreal Aflibercept Injection
18 Enrolling by invitation The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: intravitreal injection with anterior paracentesis
19 Completed Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
Condition: Central Serous Chorioretinopathy
Interventions: Device: subthreshold micropulselaser;   Drug: bevacizumab
20 Unknown  Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: PDT

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years